Filing Details
- Accession Number:
- 0001179110-21-001553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 19:07:26
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 19:07:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals Ltd. | KNSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532218 | K Sanj Patel | C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM11 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Shares | Acquisiton | 2021-02-08 | 4,924 | $1.59 | 4,924 | No | 4 | M | Direct | |
| Class A Common Shares | Disposition | 2021-02-08 | 4,924 | $23.00 | 0 | No | 4 | S | Direct | |
| Class A Common Shares | Acquisiton | 2021-02-09 | 20,401 | $1.59 | 20,401 | No | 4 | M | Direct | |
| Class A Common Shares | Disposition | 2021-02-09 | 20,401 | $23.04 | 0 | No | 4 | S | Direct | |
| Class A Common Shares | Disposition | 2021-02-08 | 4,528 | $23.00 | 108,042 | No | 4 | S | Indirect | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| Class A Common Shares | Disposition | 2021-02-09 | 23,569 | $23.08 | 84,473 | No | 4 | S | Indirect | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| Class A Common Shares | Acquisiton | 2021-02-10 | 1,600 | $1.59 | 1,600 | No | 4 | M | Direct | |
| Class A Common Shares | Disposition | 2021-02-10 | 1,600 | $23.06 | 0 | No | 4 | S | Direct | |
| Class A Common Shares | Disposition | 2021-02-10 | 1,137 | $23.07 | 83,336 | No | 4 | S | Indirect | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| No | 4 | S | Indirect | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Shares | Share Option | Disposition | 2021-02-08 | 4,924 | $0.00 | 4,924 | $1.59 |
| Class A Common Shares | Share Option | Disposition | 2021-02-09 | 20,401 | $0.00 | 20,401 | $1.59 |
| Class A Common Shares | Share Option | Disposition | 2021-02-10 | 1,600 | $0.00 | 1,600 | $1.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 347,272 | 2025-12-15 | No | 4 | M | Direct | |
| 326,871 | 2025-12-15 | No | 4 | M | Direct | |
| 325,271 | 2025-12-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Shares | 109,795 | Indirect | Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 |
Footnotes
- The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.
- The option is fully vested and exercisable.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.24. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.02. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Billionaire Hedge Funds
